Announced
Completed
Financials
Tags
Completed
Private
clinical research organization
Biotechnology
Germany
Acquisition
Friendly
Private Equity
Single Bidder
Test Inspection and Certification (TIC)
Synopsis
Canopy Biosciences LLC, a leading provider of gene editing and gene expression products and services, acquired Zellkraftwerk GmbH, a leader in multiplex cytometry. Financial terms were not disclosed. The deal was concluded after Canopy closed a strategic growth investment from Ampersand Capital Partners. "We are excited to partner with Canopy Biosciences and Ampersand to enhance our capabilities, scale, and geographic reach in the US, Europe, and Asia as we strive to best serve the evolving needs of our customers.”, Jan Detmers, Zellkraftwerk Cofounder.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.